Holen Sie sich die Stockscreener-App
8.70
0.23%
0.02
Handel nachbörslich:
8.74
0.04
+0.46%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NVAX?
Forum
Prognose
Aktiensplit
Novavax Inc Aktie (NVAX) Neueste Nachrichten
NVAX Starts Late-Stage Study on COVID-19-Flu Combo & Flu Vaccines - MSN
Novavax Inc. stock rises Friday, still underperforms market - MarketWatch
Peering Into Novavax's Recent Short Interest - Benzinga
(NVAX) Trading Advice - Stock Traders Daily
Wellington Management Group LLP Makes New $923,000 Investment in Novavax, Inc. (NASDAQ:NVAX) - MarketBeat
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Novavax adjusts vaccine deal with Australian government - Investing.com
Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Barclays PLC Raises Stock Position in Novavax, Inc. (NASDAQ:NVAX) - MarketBeat
Novavax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Novavax, Inc. (NASDAQ:NVAX) Shares Fly 26% But Investors Aren't Buying For Growth - Simply Wall St
Novavax, Inc. (NASDAQ:NVAX) Shares Acquired by State Street Corp - MarketBeat
Notable Monday Option Activity: AVAV, NKE, NVAX - Nasdaq
Adult Vaccines Market Generated Opportunities, Future Scope - openPR
Novavax, Inc. (NASDAQ:NVAX) Shares Sold by Tidal Investments LLC - MarketBeat
Novavax Earns $50 Million from Sanofi Partnership - Precision Vaccinations
Novavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50 Million Milestone - Quantisnow
Novavax to Participate in Jefferies London Healthcare Conference - The Eastern Progress Online
Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell In December 2024? - Investor's Business Daily
Novavax achieves $50M milestone in Sanofi partnershi - Investing.com
Why Is Novavax (NVAX) Up 13.6% Since Last Earnings Report? - Yahoo Finance
Institutional investors control 53% of Novavax, Inc. (NASDAQ:NVAX) and were rewarded last week after stock increased 6.3% - Yahoo Finance
Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4) - The Eastern Progress Online
Novavax Inc. stock rises Wednesday, still underperforms market - MarketWatch
Novavax to Participate in Upcoming September Conferences - The Eastern Progress Online
Novavax Initiates Phase 3 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza - Quantisnow
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know - MSN
Novavax starts Phase 3 trial for dual COVID-19/flu vaccine - Investing.com
Novavax Launches Phase 3 Trial for Revolutionary COVID-Flu Combo Vaccine in Elderly Population - StockTitan
Novavax 2024-2025 Formula COVID-19 Vaccine Available at Major Pharmacies Across the U.S. - The Eastern Progress Online
Cramer's Lightning Round: 'I'm not a fan of Novavax' - CNBC
Two Sigma Advisers LP Grows Stake in Novavax, Inc. (NASDAQ:NVAX) - MarketBeat
Novavax, Inc. (NASDAQ:NVAX) Holdings Lowered by BNP Paribas Financial Markets - MarketBeat
Charles Schwab Investment Management Inc. Boosts Stock Position in Novavax, Inc. (NASDAQ:NVAX) - MarketBeat
Update on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial - The Eastern Progress Online
Novavax (NASDAQ:NVAX) Trading 10.1% HigherShould You Buy? - MarketBeat
Stock Traders Buy High Volume of Novavax Call Options (NASDAQ:NVAX) - MarketBeat
Deal Dispatch: Ubisoft In Buyout Talks, Dental Supplier Explores Sale, Beloved Drive-Through Goes Bankrupt - Benzinga
FY2024 EPS Estimates for Novavax Decreased by Zacks Research - MarketBeat
Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S. - The Eastern Progress Online
Noteworthy Friday Option Activity: NVAX, MTDR, MU - Nasdaq
Protecting Life-Saving IP: Novavax Strengthens Security with Threat Intelligence-Driven Security - Recorded Future
Novavax (NVAX) Shares Surge as Czech Facility Sold to Novo Nordi - GuruFocus.com
Institutional investors may overlook Novavax, Inc.'s (NASDAQ:NVAX) recent US$51m market cap drop as long-term gains remain positive - Simply Wall St
Novavax Inc. stock remains steady Thursday, still outperforms market - MarketWatch
Novavax to Sell Czech Manufacturing Plant to Novo Nordisk for $200M - Yahoo Finance
Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell? - Yahoo! Voices
2 Beaten-Down "Pandemic Stocks" to Consider for Contrarian Investors - AOL
Novo expands EU footprint with $200m Novavax plant - BioProcess Insider
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):